Top Markets
Coin of the day
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc.

9606
Rangering i aksjer #6040
Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc.... Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc. concentrates on pioneering next-generation antibody-drug conjugate (ADC) therapies and proprietary duality immune toxin antibody conjugate (ITAC) solutions. The firm was founded by Zhu Zhong Yuan on July 3, 2019, and its main offices are situated in Shanghai, China.
Aksjekurs
$25.01
Markedsverdi
$2.26B
Endring (1 dag)
-1.21%
Endring (1 år)
-37.74%
Land
CN
Handel Duality Biotherapeutics, Inc. (9606)

Kategori

Pris 9606 pris med markedsverdi på B
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.
9606
$25.01
Markedsverdi av Duality Biotherapeutics, Inc.(9606)
Markedsverdi: $2.26B
Per August 2026 har Duality Biotherapeutics, Inc. en markedsverdi på $2.26B. Dette gjør Duality Biotherapeutics, Inc. til det 6040th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Duality Biotherapeutics, Inc. fra 2025 til 2026
9606 sammenlignet med topp 5 mest populære stocks
Pris på 9606 Eiendel B Markedsverdi for B Resultater
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.
$60,202.39 $2.26B
$5.447T +240,617.35%
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.
$50,812.75 $2.26B
$4.597T +203,073.16%
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.
$45,360.96 $2.26B
$4.104T +181,274.36%
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.
$41,411.50 $2.26B
$3.747T +165,482.54%
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.
$30,541.33 $2.26B
$2.763T +122,018.52%